When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Start Date: January 5, 2017
Expiration Date: January 5, 2020
Diabetes is a chronic disease state with no known cure. For this reason, diabetes management is intended to prevent complications and improve the patient’s quality of life. As a result of its high incidence and economic burden, diabetes management is an area of tremendous research. Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for healthcare providers. In addition, new guidelines for the treatment of diabetes have been released by both the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE). In order to effectively manage patients with diabetes, it is important to stay current with the standard of care for treatment of diabetes and the therapeutic options available. It is the aim of this course to review the current treatment guidelines for type 2 diabetes management and the pharmacotherapies available on the market today. Although insulin can be used to treat type 2 diabetes, the focus will remain on non-insulin therapies.
Universal Activity Number (UAN) - 0607-0000-17-017-H01-P
Type of Activity - Knowledge
Topic Designator - 01 – Disease State Management/Drug Therapy
This course is an extract of, and should not be taken in conjunction with, Y8006 - Diabetes Management: Pharmacotherapy Options for Diabetes Mellitus.
- Recognize complications and comorbid conditions associated with diabetes.
- Identify appropriate treatment goals for a patient with diabetes.
- Compare and contrast the safety and efficacy of non-insulin pharmacotherapies used in the management of type 2 diabetes.
- Identify adverse events that patients may experience while using pharmacotherapy for diabetes management and contraindications to therapy.
Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP, is an associate professor of pharmacy practice in the School of Pharmacy – Boston at MCPHS University (formerly Massachusetts College of Pharmacy and Health Sciences). He also maintains a clinical practice site with the VA Boston Healthcare System, where he functions as a mid-level provider for a variety of chronic diseases such as diabetes, hypertension, dyslipidemia, and obesity. He earned his PharmD from MCPHS University and received his postdoctoral residency training at the VA Boston Healthcare System. He is also board-certified in advanced diabetes management (BC-ADM), as an ambulatory care pharmacist (BCACP), and as a diabetes educator (CDE). Dr. Patel is one of the co-authors of the Obesity and Diabetes chapters in Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs, the first clinical pharmacy textbook to be based on patient case histories. This book is now in its 11th edition, has been translated into many languages, and is widely used in the United States and internationally. Dr. Patel has also been published in numerous peer-reviewed journals and has delivered numerous presentations and lectures on obesity.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and have your record transmitted to your NABP e-Profile account.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.